Adventa BhdXKLS:7191 36 ROA % is -7.33% as of Mar. 2026. GuruFocus rates XKLS:7191 with a GF Score™ of 36/100 and a GF Value™ of RM0.24 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 857 Medical Devices & Instruments companies, Adventa Bhd ranks worse than 62.66% on this metric.
ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Adventa Bhd's annualizedNet Income for the quarter that ended in Mar. 2026 was RM-7.88 Mil.
Adventa Bhd's average Total Assets over the quarter that ended in Mar. 2026 was RM107.56 Mil. Therefore, Adventa Bhd's annualized ROA % for the quarter that ended in Mar. 2026 was -7.33%.
The historical rank and industry rank for Adventa Bhd's ROA % or its related term are showing as below:
XKLS:7191'
s ROA % Range Over the Past 10 Years
Min: -12.88 Med: 0.31 Max: 19.57
Current: -6.98
During the past 13 years, Adventa Bhd's highest ROA % was 19.57%. The lowest was -12.88%. And the median was 0.31%.
XKLS:7191's ROA % is ranked worse than 62.66% of 857
companies
in the Medical Devices & Instruments industry
Industry Median: 0.56
vs XKLS:7191: -6.98
Adventa Bhd (XKLS:7191) ROA % Explanation
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
Adventa Bhd ROA % Related Terms
Adventa Bhd ROA % Historical Data
* Premium members only.
The historical data trend for Adventa Bhd's ROA % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Adventa Bhd's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Adventa Bhd ROA % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Adventa Bhd's ROA % distribution charts can be found below:
* The bar in red indicates where Adventa Bhd's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
ROA % is displayed in the 30-year financial page.
Adventa Bhd (XKLS:7191) has a ROA % of -7.33% as of Mar. 2026. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Adventa Bhd and its competitors. According to the industry distribution chart, Adventa Bhd ranks #537 out of 857 companies in the Medical Devices & Instruments industry, placing it in the top 62.7%.
Is Adventa Bhd's ROA % too high?
Adventa Bhd's current ROA % is -7.33%. Based on the distribution chart, Adventa Bhd ranks #537 out of 857 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Adventa Bhd has a GF Score™ of 36/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Adventa Bhd's ROA % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Adventa Bhd ranks #537 out of 857 companies for ROA %. This places Adventa Bhd in the lower half of its industry. The industry median ROA % is 0.56. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Medical Devices & Instruments company?
The median ROA % among Medical Devices & Instruments companies is 0.56, based on 857 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Adventa Bhd and its competitors. For the Medical Devices & Instruments industry, the median ROA % is 0.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Adventa Bhd's current ROA % is -7.33%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Adventa Bhd stock overvalued right now?
Based on GuruFocus' analysis, Adventa Bhd (XKLS:7191) is currently considered Possible Value Trap. The stock's GF Value™ is RM0.24, compared to a current price of RM0.13 — trading 45.8% below its estimated fair value. The current ROA % is -7.33%. Adventa Bhd's overall GF Score™ is 36/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For Adventa Bhd (XKLS:7191), the current ROA % is -7.33% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Adventa Bhd (XKLS:7191) Overvalued in 2026?
Based on GuruFocus' analysis, Adventa Bhd stock appears to be undervalued.
The current stock price of RM0.13 is trading 45.8% below its estimated GF Value™ of RM0.24.
GuruFocus considers Adventa Bhd to be Possible Value Trap.
Key valuation signals for XKLS:7191:
ROA %: -7.33%
GF Value™: RM0.24 vs. price of RM0.13 (45.8% below fair value)
No single metric tells the full story. See the XKLS:7191 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Adventa Bhd is engaged in investment holdings, management services, warehousing services, and the manufacturing, distribution, and supply of medical and healthcare equipment, appliances, and medical disposal products. It operates as a regional healthcare group focused on medical innovation, manufacturing excellence, and patient-centered solutions. Its segments include Investment Holdings, which involves investment in companies; Healthcare Products, which involves the manufacturing and supply of healthcare-related products and services to hospitals, healthcare centres, and pharmacies and generates maximum revenue; and Warehousing Provider, which provides storage and warehousing services. The company generates maximum revenue from Malaysia, followed by Indonesia and other countries.
36GF Score
Get the complete analysis for XKLS:7191
ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:7191 has been successfully added to your 
